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Abstract
Background: Streptococcus suis is a zoonotic pathogen which represents the leading cause of meningitis in
Southeast Asia and an emerging pathogen in the Western world, the main risk factor for infection being contact
with pigs. In Africa, the prevalence of S. suis infections in swine and humans is largely unrecognized, with only one
recent report of a limited case series.
Case presentation: We describe a human case of meningitis due to S. suis in a 32-year-old man living in Togo. The
patient had no particular medical history and no risk factors for immunodeficiency but reported regular contact
with pork products. Using specific immunological and molecular methods, we characterized the isolate as S. suis
serotype 2, ST1, one the most prevalent and virulent clone worldwide. The outcome was favorable after one week
of adapted antibiotic therapy but the patient was left with severe hearing disorders.
Conclusions: This work highlights the emergence of this pathogen in Africa and reinforces the need for accurate
epidemiological and surveillance studies of S. suis infections and for educating clinicians and exposed groups in
non-endemic countries.
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Background
Streptococcus suis is an emerging zoonotic pathogen in
Europe, North-America and South-America [1, 2]. This
encapsulated gram-positive coccus is responsible for men-
ingitis, bacteremia, and pneumonia in swine and is mainly
associated with meningitis and endocarditis in humans.
Incidence is highly correlated to contact with pigs and
eating of undercooked pork products, habits which are
common in Southeast Asia where S. suis is endemic and
represents the leading cause of meningitis in adults [1, 2].
In the Western world, rates of S. suis infection are low
and the vast majority of the cases involves highly-exposed
groups such as abattoir workers and pig breeders [1].
Mortality rate reaches approx. 3 % and neurologic seque-
lae in case of meningitis are frequent (60 %), making the
global burden of S. suis infections in endemic countries
significant [2]. We report, according to the CARE guide-
lines, a human case of meningitis due to S. suis in Africa
where the prevalence of this bacterium in swine and
humans is largely unrecognized.
Case presentation
A 32-year-old man working as a carpenter in Lomé, Togo,
was admitted in August 2015 to the University Hospital
Campus of Lomé for a 3 day history of severe headaches,
vomiting, fever, and intense agitation (Table 1). He had no
particular medical history and no risk factors for immuno-
deficiency. At admission, the body temperature was of
36.4 °C, and the general state was acceptable, with a correct
conservation of consciousness. The neurological examin-
ation did not show any sign of motor or sensitive defect, of
cranial nerve dysfunction or cerebellar symptoms. There
was no hearing or skin abnormalities, no obvious neck
stiffness, and the rest of the clinical examination was
normal. Acute meningeal hemorrhage was evocated as the
initial diagnosis. Cranial computed tomography could not
be performed and a symptomatic treatment associating
antalgic, antipyretic, and anticonvulsant medication was
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Table 1 Case-patient timeline
Presenting concerns Physical examination Evaluations Diagnosis Interventions-Treatments
Day of admission 32-year-old man, carpenter in Lomé
No particular medical history
3-day history of headaches,
agitation, vomiting, fever





Acute meningeal hemorrhage Symptomatic treatment
Day 2 Persisting symptoms
Fever
Neck stiffness Kernig and Brudzinski
signs positive
Lumbar puncture: turbid CSFa
CSF analysis:
-WBCa: 2,800/mm3
(65 % lymphocytes,35 % neutrophils)
- Protein: 1.8 g/L
- Glucose: 0.47 g/L
(plasma 1.41 g/L; ratio = 0.33)














Day 4 Patient reported working as a
pork butcher every weekend
Bacterial identification: Streptococcus suis
Audiogram: severe hearing loss in l
eft and right ears (80 dB)
Bacterial meningitis due to S. suis
with neurological complications
Month 9 Tinnitus Audiogram: severe hearing loss
in left and right ears (80 dB)
Neurological sequelae
of the meningitis














initiated. At the second day of admission, the patient was
febrile, agitated, and still suffered from severe headaches
and vomiting. The neck had become stiff, and Kernig and
Brudzinski signs were positive. The meningeal signs led to
the realization of a lumbar puncture, which yielded a turbid
cerebrospinal fluid (CSF) concluding to the diagnosis of
bacterial meningitis. An empiric intravenous antibiotic
treatment associating ceftriaxone (2 g, 2×/d for 24 h then
1 g, 2×/d), ofloxacin (200 mg, 3×/d), and metronidazole
(500 mg, 2×/d) was started.
CSF analysis showed 2,800 leukocytes/mm3 (65 % lym-
phocytes and 35 % neutrophils), a protein concentration
of 1.8 g/L, and a glucose concentration of 0.47 g/L
(2.6 mmol/L) with a plasma glucose concentration of
1.41 g/L (7.8 mmol/L; ratio = 0.33). Gram staining did not
reveal any microorganism. Blood and CSF cultures, after
48 h and 24 h of incubation, respectively, grew small
beta-hemolytic colonies on horse blood agar plates. The
bacteria were catalase negative, gram-positive cocci, in
chains or in pairs. They were identified as S. suis (score 2.56)
by MALDI-TOF (Matrix Assisted Laser Desorption Ionisa-
tion Time Of Flight) spectrometry (BrukerTM) and as S.
suis serotype 1 (97 % probability) by VITEK 2 Gram-
positive card system (bioMérieux, Marcy l’Etoile, France).
Slide agglutination with type-specific hyperimmune serum
and specific multiplex PCR identified the isolate as S. suis
serotype 2, indicating a serotype misidentification by the au-
tomated card system, and concluding, together with Multi-
Locus Sequence Typing [3–5], to an infection due to S. suis
serotype 2, Sequence-Type (ST) 1, one of the most virulent
and frequently isolated clone all over the world [1, 6]. Anti-
microbial drug-susceptibility testing performed according to
the European Committee on Antimicrobial Susceptibility
Testing (EUCAST) recommendations characterized the
strain as susceptible to penicillin (Minimum inhibitory con-
centration (MIC) < =0.25 mg/L), erythromycin, clindamycin,
levofloxacin, and linezolid and resistant to tetracycline.
After S. suis was identified, the patient reported work-
ing as a pork butcher every week-end. The patient did
not have any sign or symptoms of endocarditis, and the
antibiotic treatment was replaced by ampicillin (2 g, 3×/
d) and gentamicin (80 mg, 2×/d) for 7 days. While the
patient was receiving treatment for 1 day, vertigo and
tinnitus developed, for which he received adjunctive
corticoid therapy and the treatment was completed with
no particular adverse events. Hearing disorders, espe-
cially hearing loss, are the most common sequelae of S.
suis infections and affect more than 50 % of patients
who survive meningitis [2]. In that case, hearing disor-
ders evolved into severe hearing loss in the left and right
ears (80 dB), and the patient was still suffering from
tinnitus 9 months after the diagnosis. One year later,
tinnitus had disappeared and the patient’s auditory func-
tion had improved from severe to moderate hearing loss.
Conclusions
Data for circulation and epidemiology of S. suis in Africa
remain extremely scarce. This is the second report of a
human S. suis meningitis in Togo, which, together with a
recently published limited case-series [7], highlights the
emergence of this zoonotic pathogen in Africa. Neverthe-
less, swine industry and pork products consumption,
although extremely low compared to other continents, are
steadily increasing [8], which might lead to a significant rise
of S. suis infections in the future. Besides, S. suis infections
are not limited to adult cases but also affect children [7],
and specific attention should be paid to this other potential
high-risk group. This case-report, for which clinical data,
microbiological findings, and outcome were similar to those
reported elsewhere [1, 2], emphasizes the need for edu-
cating both clinicians and exposed groups about S. suis
infections and their severity in non-endemic countries.
Particularly, accurate epidemiological and surveillance
studies appear essential to assess the global burden of S.
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